|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
NZ262807A
(en)
*
|
1993-03-03 |
1997-11-24 |
Glaxo Wellcome Inc |
Inhalator; medicament carrier for dry powder inhalator has a portion with a plurality of interstices, for a predetermined dose
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
NZ322422A
(en)
|
1995-12-07 |
2000-02-28 |
Jago Pharma Ag |
Inhalator designed to provide multiple doses of a dry pharmacological powder
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(fr)
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Appareil inhalateur
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
HUP0300491A2
(en)
|
2000-02-28 |
2003-07-28 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
CA2477604A1
(fr)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation de la methylation de proteines et du phosphate des phosphoproteines
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
US8221804B2
(en)
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
US8653028B2
(en)
|
2005-04-29 |
2014-02-18 |
Rui Rong Yuan |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US20070049641A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Rabindra Tirouvanziam |
Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
*
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
US8741849B2
(en)
*
|
2007-01-10 |
2014-06-03 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
|
CA2689296C
(fr)
|
2007-01-10 |
2015-11-17 |
Purdue Research Foundation |
Inhibiteurs polypeptidiques de la hsp27 kinase et leurs utilisations
|
|
WO2009100383A2
(fr)
|
2008-02-07 |
2009-08-13 |
University Of Washington |
Dispositif aérosol périphérique
|
|
KR20110028457A
(ko)
*
|
2008-05-21 |
2011-03-18 |
뉴로테즈 인코포레이티드 |
신경섬유 매듭과 연관된 신경변성 장애를 치료하는 방법
|
|
AR072114A1
(es)
*
|
2008-06-13 |
2010-08-04 |
Mannkind Corp |
Un inhalador de polvo seco y sistema para suministro de farmacos
|
|
JP5785085B2
(ja)
*
|
2008-10-20 |
2015-09-24 |
モイライ マトリックス インコーポレイテッド |
癒着を処置又は防止するためのポリペプチド
|
|
CA2742600A1
(fr)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Compositions a base de leptine et methodes de traitement de troubles evolutifs de la fonction cognitive provoques par une accumulation d'enchevetrements neurofibrillaires et de beta-amyloide
|
|
CA2744104C
(fr)
*
|
2008-12-10 |
2017-07-18 |
Purdue Research Foundation |
Inhibiteur permeant cellulaire de kinases a base peptidique
|
|
CN102762573B
(zh)
|
2009-07-24 |
2015-09-16 |
阿马曾提斯公司 |
用于在神经退行性障碍中保护脑部健康的化合物、组合物和方法
|
|
WO2011017132A2
(fr)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Compositions d'inhibiteurs de mk2 et procédés d'amélioration de l'excroissance des neurites, de la neuroprotection et de la régénération des nerfs
|
|
RU2728583C2
(ru)
|
2011-03-03 |
2020-07-30 |
Импел Ньюрофарма Инк. |
Устройство для назальной доставки лекарственных средств
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
KR101862291B1
(ko)
|
2011-04-12 |
2018-05-29 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
|
|
EP2701712B1
(fr)
|
2011-04-25 |
2017-06-21 |
Cornell University |
Utilisation d'uridine et de désoxyuridine pour traiter les pathologies répondant aux folates
|
|
RU2618084C2
(ru)
|
2011-05-09 |
2017-05-02 |
Импел Ньюрофарма Инк. |
Наконечники для назальной доставки лекарственных средств
|
|
EP2589381B1
(fr)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
|
|
US9452218B2
(en)
|
2012-03-09 |
2016-09-27 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
|
CN115414384A
(zh)
|
2012-09-04 |
2022-12-02 |
埃莱森制药有限责任公司 |
用顺铂脂质复合物预防癌症的肺部复发
|
|
US10537692B2
(en)
|
2013-04-28 |
2020-01-21 |
Impel Neuropharma, Inc. |
Medical unit dose container
|
|
WO2015006639A1
(fr)
|
2013-07-12 |
2015-01-15 |
SILVA, John, H. |
Pièce buccale pour inhalateur
|
|
EP3044218B1
(fr)
|
2013-09-10 |
2020-05-27 |
Board Of Regents Of the University Of Texas System |
Thérapie ciblant des protéines polypose adénomateuse familiale (apc) tronquées
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
AU2015350151A1
(en)
|
2014-11-17 |
2017-06-01 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
EP3229831B1
(fr)
|
2014-12-10 |
2020-03-11 |
Hyperstem SA |
Methodes et compositions pour réduire la croissance, migration et capacité invasive de cellules souches du cancer du cerveau et améliorer la survie des patients atteints de tumeurs cérébrales
|
|
SG11201705559RA
(en)
|
2015-01-08 |
2017-08-30 |
Moerae Matrix Inc |
Formulation of mk2 inhibitor peptides
|
|
JP2018512401A
(ja)
|
2015-03-12 |
2018-05-17 |
モイライ マトリックス インコーポレイテッド |
Ｍｋ２阻害剤ペプチド含有組成物を用いた非小細胞肺癌の治療を目的とするその使用
|
|
US9937154B2
(en)
|
2015-06-10 |
2018-04-10 |
Hackensak University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
|
US10112948B2
(en)
|
2015-07-06 |
2018-10-30 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
|
EP3322417B1
(fr)
|
2015-07-15 |
2023-08-23 |
The Board of Regents of The University of Texas System |
Ciblage de protéine de liaison de l'emopamil (ebp) avec de petites molécules qui induisent une réponse de rétroaction anormale par l'abaissement de la biosynthèse du cholestérol endogène
|
|
CA2998182A1
(fr)
|
2015-09-10 |
2017-03-16 |
Impel Neuropharma, Inc. |
Dispositif d'administration nasale en ligne
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
CA3011185A1
(fr)
|
2016-01-20 |
2017-07-27 |
Flurry Powders, Llc |
Encapsulation d'ingredients lipophiles dans des poudres sechees par pulverisation pouvant etre dispersees destinees a l'inhalation
|
|
CA3081680A1
(fr)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Dispositif intra-nasale avec interface d'entree
|
|
US11571532B2
(en)
|
2017-11-21 |
2023-02-07 |
Impel Pharmaceuticals Inc. |
Intranasal device with dip tube
|
|
EP3735244B1
(fr)
|
2018-01-05 |
2022-11-23 |
Impel Pharmaceuticals Inc. |
Administration intranasale de dihydroergotamine par un dispositif olfactif de précision
|
|
CA3087698A1
(fr)
|
2018-01-05 |
2019-07-11 |
Impel Neuropharma, Inc. |
Administration intranasale d'olanzapine par un dispositif olfactif de precision
|
|
KR20210034047A
(ko)
|
2018-07-19 |
2021-03-29 |
임펠 뉴로파마 인코포레이티드 |
파킨슨 병 치료를 위한 레보도파 및 도파 데카르복실라아제 저해제의 기도 전달
|
|
KR20210109007A
(ko)
|
2019-01-03 |
2021-09-03 |
임펠 뉴로파마 인코포레이티드 |
비강 약물 전달 장치
|
|
BR112021023049A8
(pt)
|
2019-05-17 |
2022-10-18 |
Impel Neuropharma Inc |
Dispositivo de dispensação nasal de uso único
|